These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23207485)

  • 41. Altered NCAM expression associated with the cholinergic system in Alzheimer's disease.
    Aisa B; Gil-Bea FJ; Solas M; García-Alloza M; Chen CP; Lai MK; Francis PT; Ramírez MJ
    J Alzheimers Dis; 2010; 20(2):659-68. PubMed ID: 20164549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma antibodies to Abeta40 and Abeta42 in patients with Alzheimer's disease and normal controls.
    Xu W; Kawarabayashi T; Matsubara E; Deguchi K; Murakami T; Harigaya Y; Ikeda M; Amari M; Kuwano R; Abe K; Shoji M
    Brain Res; 2008 Jul; 1219():169-79. PubMed ID: 18534566
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The leukocyte expression of CD36 is low in patients with Alzheimer's disease and mild cognitive impairment.
    Giunta M; Rigamonti AE; Scarpini E; Galimberti D; Bonomo SM; Venturelli E; Müller EE; Cella SG
    Neurobiol Aging; 2007 Apr; 28(4):515-8. PubMed ID: 16563568
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trichostatin A increases the levels of plasma gelsolin and amyloid beta-protein in a transgenic mouse model of Alzheimer's disease.
    Yang W; Chauhan A; Mehta S; Mehta P; Gu F; Chauhan V
    Life Sci; 2014 Mar; 99(1-2):31-6. PubMed ID: 24486299
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anomalously phosphorylated tau and Abeta fragments in the CSF correlates with cognitive impairment in MCI subjects.
    Maccioni RB; Lavados M; Guillón M; Mujica C; Bosch R; Farías G; Fuentes P
    Neurobiol Aging; 2006 Feb; 27(2):237-44. PubMed ID: 16399209
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging.
    Lui JK; Laws SM; Li QX; Villemagne VL; Ames D; Brown B; Bush AI; De Ruyck K; Dromey J; Ellis KA; Faux NG; Foster J; Fowler C; Gupta V; Hudson P; Laughton K; Masters CL; Pertile K; Rembach A; Rimajova M; Rodrigues M; Rowe CC; Rumble R; Szoeke C; Taddei K; Taddei T; Trounson B; Ward V; Martins RN; AIBL Research Group
    J Alzheimers Dis; 2010; 20(4):1233-42. PubMed ID: 20413897
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene expression profiling of peripheral blood leukocytes shows consistent longitudinal downregulation of TOMM40 and upregulation of KIR2DL5A, PLOD1, and SLC2A8 among fast progressors in early Alzheimer's disease.
    Chong MS; Goh LK; Lim WS; Chan M; Tay L; Chen G; Feng L; Ng TP; Tan CH; Lee TS
    J Alzheimers Dis; 2013; 34(2):399-405. PubMed ID: 23234877
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased midkine levels in sera from patients with Alzheimer's disease.
    Salama RH; Muramatsu H; Shimizu E; Hashimoto K; Ohgake S; Watanabe H; Komatsu N; Okamura N; Koike K; Shinoda N; Okada S; Iyo M; Muramatsu T
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):611-6. PubMed ID: 15866365
    [TBL] [Abstract][Full Text] [Related]  

  • 49. α-Synuclein mRNA and soluble α-synuclein protein levels in post-mortem brain from patients with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease.
    Quinn JG; Coulson DT; Brockbank S; Beyer N; Ravid R; Hellemans J; Irvine GB; Johnston JA
    Brain Res; 2012 Jun; 1459():71-80. PubMed ID: 22560502
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    Kumar A; Bagri K; Nimbhal M; Kumar P
    J Biomol Struct Dyn; 2021 Nov; 39(18):7181-7193. PubMed ID: 32795153
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
    Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
    Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Developmental expression and subcellular localization of glutaminyl cyclase in mouse brain.
    Hartlage-Rübsamen M; Staffa K; Waniek A; Wermann M; Hoffmann T; Cynis H; Schilling S; Demuth HU; Rossner S
    Int J Dev Neurosci; 2009 Dec; 27(8):825-35. PubMed ID: 19699792
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease.
    Velayudhan L; Proitsi P; Westman E; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Hodges A; Powell J; Lovestone S; Simmons A;
    J Alzheimers Dis; 2013; 33(3):755-66. PubMed ID: 23047370
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence for tissue-specific forms of glutaminyl cyclase.
    Sykes PA; Watson SJ; Temple JS; Bateman RC
    FEBS Lett; 1999 Jul; 455(1-2):159-61. PubMed ID: 10428492
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic potential of glutaminyl cyclases: Current status and emerging trends.
    Coimbra JRM; Moreira PI; Santos AE; Salvador JAR
    Drug Discov Today; 2023 Oct; 28(10):103644. PubMed ID: 37244566
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potent human glutaminyl cyclase inhibitors as potential anti-Alzheimer's agents: Structure-activity relationship study of Arg-mimetic region.
    Ngo VTH; Hoang VH; Tran PT; Ann J; Cui M; Park G; Choi S; Lee J; Kim H; Ha HJ; Choi K; Kim YH; Lee J
    Bioorg Med Chem; 2018 Mar; 26(5):1035-1049. PubMed ID: 29398442
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TREM1 mRNA Expression in Leukocytes and Cognitive Function in Japanese Patients with Alzheimer's Disease.
    Sao T; Yoshino Y; Yamazaki K; Ozaki Y; Mori Y; Ochi S; Yoshida T; Mori T; Iga JI; Ueno SI
    J Alzheimers Dis; 2018; 64(4):1275-1284. PubMed ID: 30010135
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Piperidine-4-carboxamide as a new scaffold for designing secretory glutaminyl cyclase inhibitors.
    Dileep KV; Sakai N; Ihara K; Kato-Murayama M; Nakata A; Ito A; Sivaraman DM; Shin JW; Yoshida M; Shirouzu M; Zhang KYJ
    Int J Biol Macromol; 2021 Feb; 170():415-423. PubMed ID: 33373636
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A spectrophotometric assay for glutaminyl-peptide cyclizing enzymes.
    Bateman RC
    J Neurosci Methods; 1989 Oct; 30(1):23-8. PubMed ID: 2811431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.